A SYSTEMATIC REVIEW OF THE APPLICATION OF NATURAL POLYMERS IN THE FORMULATION OF ORO-DISPERSIBLE TABLET

DHANANJAY PRAKASH; VIMAL ARORA; HITESH KUMAR DEWANGAN

doi:10.22159/ijap.2023v15i5.48183

Authors

DHANANJAY PRAKASH University Institute of Pharma Sciences (UIPS), Chandigarh University NH-5, Chandigarh Ludhiana Highway, Mohali Punjab, India
VIMAL ARORA University Institute of Pharma Sciences (UIPS), Chandigarh University NH-5, Chandigarh Ludhiana Highway, Mohali Punjab, India
HITESH KUMAR DEWANGAN University Institute of Pharma Sciences (UIPS), Chandigarh University NH-5, Chandigarh Ludhiana Highway, Mohali Punjab, India https://orcid.org/0000-0003-3440-1884

DOI:

https://doi.org/10.22159/ijap.2023v15i5.48183

Keywords:

Oral drug transport, Orodispersible tablets, Conventional tablets, Natural polymers

Abstract

Oral drug delivery is still the preferred method for administering many medications. Recent technological advancements have led to the development of orally disintegrating drugs, which offer improved patient compliance and convenience. Orodispersible(ODTs) drugs are a unique dosage form that dissolves in the mouth within 1-3 min without the need for chewing or water. Over the past three decades, orodispersible drugs have gained popularity as an alternative to traditional drugs due to their increased patient compliance, solubility, and stability. This new technology meets both the pharmaceutical and patient demands and provides a comfortable dosage method for pediatric, geriatric, and psychiatric patients with dysphagia. Natural substances are preferred over synthetic ones because they are more accessible, less expensive, non-toxic, and chemically inert. Natural polymers, such as locust bean gum, banana powder, mango peel pectin, and Mangifera indica gum, enhance drug characteristics and are used as binders, diluents, and super disintegrants to speed up disintegration, increase solubility, and provide supplements. Manufacturers are increasingly using natural polymers due to various issues with medication release and adverse effects. This review article views the development of ODTs, challenges in formulation, new ODT technologies, and our suspects.

Downloads

Download data is not yet available.

References

Das SK. Solid dispersions: an approach to enhance the bioavailability of poorly water-soluble drugs. IJPPT. 2013:37-46. doi: 10.47893/IJPPT.2013.1006.

Sharma D, Soni M, Kumar S, Gupta GD. Solubility enhancement-eminent role in poorly soluble drugs. Res J Pharm Technol. 2009;2(2):220-4. doi: 10.5958/0974-360X.2009.00364.6.

Patel T, Patel L, Patel T, Makwana S, Patel T. Enhancement of dissolution of fenofibrate by solid dispersion technique. Int J Res Pharm Sci. 2010;1(2):127-32. doi: 10.7897/2230-8407.01218p.

Weuts I, Kempen D, Verreck G, Peeters J, Brewster M, Blaton N. Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage. Eur J Pharm Sci. 2005;25(4-5):387-93. doi: 10.1016/j.ejps.2005.04.011. PMID 15894472.

Bramhmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics-a treatise. 2nd ed Vallabh Prakashan;2005. p. 24-30, 314-36.

Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst. 2004;21(6):433-76. doi: 10.1615/CritRevTherDrugCarrierSyst.v21.i6.10.

Bradoo R, Shahani S, Poojary S, Deewan B, Sudarshan S. Fast dissolving drug delivery system. JAMA India. 2001;4(10):27-31.

Seager H. Drug-delivery products and the zydis fast-dissolving dosage form. J Pharm Pharmacol. 1998;50(4):375-82. doi: 10.1111/j.2042-7158.1998.tb06876.x. PMID 9625481.

Les MC, Atherton AD, Copping NM. Freeze-dried dosage forms and methods for preparing the same. United States Patent US. 1993;5(188):825.

Chaudhary H, Gauri S, Rathee P, Kumar V. Development and optimization of fast dissolving oro-dispersible films of granisetron HCl using box-behnken statistical design. Bull Fac Pharm Cairo Univ. 2013;51(2):193-201. doi: 10.1016/j.bfopcu.2013.05.002.

Chang RK, Xiaodi G, Burnside BA, Couch RA. Fast-dissolving tablets. Pharm Technol. 2000;24(6):52-8.

Luca D. Fast melting tablets development and technologies. Pharm Technol Drug Deliv. 2001;3:44-50.

Kuchekar BS, Bhise SB, Arumugam V. Design of fast dissolving tablets. Indian J Pharm Educ. 2001;35(4):150-2.

De Paula IC, Ortega GG, Bassani VL, Petrovick PR. Development of ointment formulations prepared with achyrocline satureioides spray-dried extracts. Drug Dev Ind Pharm. 1998;24(3):235-41. doi: 10.3109/03639049809085615. PMID 9876580.

Prasad YV, Krishna DV, Krishna JR, Reddy KP, Reddy MN. Taste masking techniques in oral disintegrating tablets: a review. Int J Pharm Pharm Sci. 2010;2Suppl 4:30-5.

Nakano Y, Maeda A, Uchida S, Namiki N. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets. Int J Pharm. 2013;446(1-2):160-5. doi: 10.1016/j.ijpharm.2013.02.019, PMID 23419665.

Shao Y, Wang J, Wu H, Liu J, Aksay I, Lin Y. Graphene based electrochemical sensors and biosensors: a review. Electroanalysis. 2010;22(10):1027-36. doi: 10.1002/elan.200900571.

Woertz K, Tissen C, Kleinebudde P, Breitkreutz J. Taste sensing systems (electronic tongues) for pharmaceutical applications. Int J Pharm. 2011;417(1-2):256-71. doi: 10.1016/j.ijpharm.2010.11.028, PMID 21094230.

Keck CM, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62(1):3-16. doi: 10.1016/j.ejpb.2005.05.009. PMID 16129588.

Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech. 2006;7(2):E55. doi: 10.1208/pt070255, PMID 16796372.

Harmon TM. Orally disintegrating tablets: a valuable life cycle management strategy. Pharm Comm. 2007. Available from: http://www.aptalispharmaceuticaltechnologies.com/pdf/EURX_Article_March_2007.pdf. [Last accessed on 13 Jan 2014]

FDA CDER. Guidance for industry: orally disintegrating tablets. Silver Spring, MD: FDA/Center for Drug Evaluation and Research; 2008. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070578.pdf. [Last accessed on 15 Jan 2014]

Crowley K, Bayoh K, Sultzbaugh K, Bahl D. The impact of a poorly soluble drug on the disintegration of orally disintegrating tablets made by different manufacturing technologies; 2013. Available from: http://tablet.catalent.com/var/plain_site/storage/original/application.

Corapçioglu F, Sarper N. A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer. Pediatr Hematol Oncol. 2005;22(2):103-14. doi: 10.1080/08880010590896468, PMID 15804995.

Alhusban F, Perrie Y, Mohammed AR. Formulation of multi particulate systems as lyophilised orally disintegrating tablets. Eur J Pharm Biopharm. 2011;79(3):627-34. doi: 10.1016/j.ejpb.2011.05.014, PMID 21693189.

Kasliwal N, Negi JS, Jugran V, Jain R. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet. Arch Pharm Res. 2011;34(10):1691-700. doi: 10.1007/s12272-011-1013-3, PMID 22076769.

Castellanos A. The relationship between attractive interparticle forces and bulk behavior in dry and uncharged fine powders. Adv Phys. 2005;54(5-6):263-376.

Gupta P. Recent advancements in taste-masking techniques for bitter drugs in oral pharmaceuticals. Int J Pharm Sci Res. 2018;9(6):2260-70. doi: 10.13040/IJPSR.0975-8232.9(6).2260-70.

Bolhuis GK, Smallenbroek AJ, Lerk CF. Interaction of tablet disintegrants and magnesium stearate during mixing I: effect on tablet disintegration. J Pharm Sci. 1981;70(12):1328-30. doi: 10.1002/jps.2600701210, PMID 7320846.

Pinho LA, Temer AC, Ribeiro C, Sa-Barreto LL, Cunha Filho MSS. The popularization of orodispersible tablets in the pharmaceutical market. Infarma 2018;30(2):77-84. doi: 10.14450/2318-9312.v30.e2.a2018.pp77-84.

Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech. 2004;5(3):e36. doi: 10.1208/pt050336, PMID 15760070.

Dey P, Maiti S. Orodispersible tablets: a new trend in drug delivery. J Nat Sci Biol Med. 2010;1(1):2-5. doi: 10.4103/0976-9668.71663. PMID 22096326.

Hirani JJ, Rathod DA, Vadalia KR. Orally disintegrating tablets: a review. Trop J Pharm Res. 2009;8(2):161-72. doi: 10.4314/tjpr.v8i2.44525.

Llorca PM. Discussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depression. Ther Deliv. 2011;2(5):611-22. doi: 10.4155/tde.11.32, PMID 22833978.

Ibrahim HK, El-Setouhy DA. Valsartan orodispersible tablets: formulation, in vitro/in vivo characterization. AAPS PharmSciTech. 2010;11(1):189-96. doi: 10.1208/s12249-009-9354-7, PMID 20112137.

Kumari PVK, Rao YS. Formulation and evaluation of orodispersible tablets of donepezil hydrochloride. Int J Curr Pharm Sci 2020;12:45-51. doi: 10.22159/ijcpr.2020v12i4.39049.

Ashish P, Harsoliya MS, Pathan JK, Shruti S. A review-formulation of mouth dissolving tablet. Int J Pharm Clin Sci. 2011;1:1-8.

Bhowmik D, Chiranjib B, Pankaj. Fast dissolving tablet: an overview. J Chem Pharm Res. 2009;1:163-77.

Vanscoil KG. Solid pharmaceutical dosage in tablet triturate form and method of producing same. US Patent 1992;5(082):667.

Pebley WS. Rapidly disintegrating tablet. US Patent 1994;5(298):261.

Nagar P, Singh K, Chauhan I, Verma M, Yasir M, Khan A. Orally disintegrating tablets: formulation, preparation techniques, and evaluation. J Appl Pharm Sci. 2011;4:35-45. doi: 10.7324/JAPS.2011.1406.

Ashish P, Harsoliya MS, Pathan JK, Shruti S. A review-formulation of mouth dissolving tablet. Int J Pharm Clin Sci. 2011;1(1):1-8. doi: 10.2139/ssrn.1923765.

Sri KV, Raj GB, Ravishanker D, Kumar CA. Preparation and evaluation of montelukast oral dispersible tablets by direct compression method. Int Res J Pharm. 2012;7:315-8. doi: 10.7897/2230-8407.07445.

Allen IV, Wang BM. Process for making a particulate support matrix for making rapidly dissolving dosage form. US Patent. 1996;5(587):180.

Shukla D. Mouth dissolving tablets i: an overview of formulation technology. Sci Pharm. 2009;77(2):309-26. doi: 10.3797/scipharm.0811-09-01.

Kumari S, Sharma PK. A review-oral dispersible tablets. Int J Pharm. 2014;4(4):290-6. doi: 10.7439/ijpp.v4i4.1595.

Patel VN, Gupta MM. Emerging trends in oral dispersible tablet. J Drug Delivery Ther 2013;3(2):199-206. doi: 10.22270/jddt.v3i2.449.

Bess WS, Kulkarni N, Ambike SH, Ramsay MP. Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at a weight ratio of 1:3 to 3:1. United States Patent 2006. p. US7067116.

Yang D, Kulkarni R, Behme RJ, Kotiyan PN. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin. Int J Pharm. 2007;329(1-2):72-80. doi: 10.1016/j.ijpharm.2006.08.029, PMID 17027207.

Patil PB, More VN, Tour NS. A recent trend in oro dispersible tablets. An overview of formulation technology and prospects. Int J Pharm Sci Res. 2015;6(7):1056-66.

Agarwal P, Arora SV. Oro dispersible tablet: a comprehensive review. Int J Res Dev Pharm Life Sci. 2013;2(2):25-41.

Mittal P, Soni KR, Mewara R. A review on recent advances of oral mouth dissolving tablet. J Drug Discov Ther. 2014;2(18):17-22.

Prateek S, Ramdayal G, Kumar SU, Ashwani C, Ashwani G, Mansi S. Fast dissolving tablet: a new venture in drug delivery. Am J Pharm Tech Res. 2012;2(4):252-79. doi: 10.5958/j.2231-5713.2.4.037.

Chandrasekaran G, Rajalakshmi AN. Fixed dose combination products as oro-dispersible tablets: a review. J Drug Delivery Ther 2019;9(2):563-73. doi: 10.22270/jddt.v9i2.2515.

Kuchekar BS, Badhan AC, Mahajan HS. Mouth dissolving tablets: a novel drug delivery system. Pharm Times. 2003;35:7-14.

Bradoo R, Shahani S, Poojary S, Deewan B, Sudarshan S. Fast dissolving drug delivery systems. JAMA India. 2001;4:27-31.

Indurwade N, Rajyaguru T, Nakhat P. Novel approach: fast dissolving tablets. Indian Drugs. 2002;8:405-9.

Shyamala B, Narmada G. Rapid dissolving tablets: a novel dosage form. Indian Pharm. 2002;8:9-12.

Satturwar PM, Fulzele SV, Dorle AK. Biodegradation and in vivo biocompatibility of rosin: a natural film-forming polymer. AAPS PharmSciTech. 2003;4:1-6. doi: 10.1208/pt040401.

Lam KS. New aspects of natural products in drug discovery. Trends Microbiol. 2007;15(6):279-89. doi: 10.1016/j.tim.2007.04.001. PMID 17433686.

McChesney JD, Venkataraman SK, Henri JT. Plant natural products: back to the future or into extinction? Phytochemistry. 2007;68(14):2015-22. doi: 10.1016/j.phytochem.2007.04.032, PMID 17574638.

Pandey R, Khuller GK. Polymer based drug delivery systems for mycobacterial infections. Curr Drug Deliv. 2004;1(3):195-201. doi: 10.2174/1567201043334669, PMID 16305383.

Chamarthy SP, Pinal R. Plasticizer concentration and the performance of a diffusion-controlled polymeric drug delivery system. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2008;331(1-2):25-30. doi: 10.1016/j.colsurfa.2008.05.047.

Alonso Sande M, Teijeiro Osorio D, Remunan Lopez C, Alonso MJ. Glucomannan, a promising polysaccharide for biopharmaceutical purposes. Eur J Pharm Biopharm. 2009;72(2):453-62. doi: 10.1016/j.ejpb.2008.02.005. PMID 18511246.

Guo J, Skinner GW, Harcum WW, Barnum PE. Pharmaceutical applications of naturally occurring water-soluble polymers. Pharm Sci Technol Today. 1998;1(6):254-61. doi: 10.1016/S1461-5347(98)00072-8.

Mahmoodi Khah H, Soleimani O. Properties and Applications of Polymers: A Mini Review. J Chem Res. 2023;5(2):204-20. doi: 10.22034/jcr.2023.383915.1213.

Beneke CE, Viljoen AM, Hamman JH. Polymeric plant-derived excipients in drug delivery. Molecules. 2009;14(7):2602-20. doi: 10.3390/molecules14072602, PMID 19633627.

Bruscato FN, Danti AG. Pharmaceutical tablets containing chitin or chitosan as a disintegrant; 1978.

Scheller HV, Jensen JK, Sørensen SO, Harholt J, Geshi N. Biosynthesis of pectin. Physiol Plant. 2007;129(2):283-95. doi: 10.1111/j.1399-3054.2006.00834.x.

Aquilera JM, Stanley DW. Microstructural principles of food processing and engineering. Berlin: Springer; 1999. p. 99-103.

Cosgrove DJ. Growth of the plant cell wall. Nat Rev Mol Cell Biol. 2005;6(11):850-61. doi: 10.1038/nrm1746, PMID 16261190.

Dumitriu SEd, Hon DNS. Cellulose and its derivatives: structures, reactions and medical uses. In: Polysaccharides in medicinal applications. New York: Marcel Dekker, Inc; 1996. p. 87-106.

Batham P, Kalichaman SG, Osborne BE. A 52-week oral toxicity study of gellan gum in the beagle dog. Bio Research Lab. Ltd, Montreal, Canada; 1986.

Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 22nd ed. India: Nirali Prakashan; 2003. p. 133-66.

Setia A, Goyal N, Kansal S. Formulation and evaluation of ciprofloxacin hydrochloride dispersible tablets using natural substances as disintegrates. Sinica: Pelagia Research Library Der Pharmacia. 2011;2(1):36-9.

Mahdi MH, Conway BR, Smith AM. Evaluation of gellan gum fluid gels as modified release oral liquids. Int J Pharm. 2014;475(1-2):335-43. doi: 10.1016/j.ijpharm.2014.08.044, PMID 25169076.

Kubo W, Miyazaki S, Attwood D. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int J Pharm. 2003;258(1-2):55-64. doi: 10.1016/s0378-5173(03)00163-7, PMID 12753753.

Mehta KK, Patel HH, Patel ND, Vora CN, Patel NJ. Comparative evaluation of natural and synthetic super disintegrant for promoting nimesulide dissolution for fast dissolving technology. Int J Pharm Pharm Sci. 2010;2(3):102-8.

Gohel MC, Amin AF, Patel KV, Panchal MK. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum. Boll Chim Farm. 2002;141(1):21-8. PMID 12064053.

Picker KM. Matrix tablets of carrageenans. I. A compaction study. Drug Dev Ind Pharm. 1999;25(3):329-37. doi: 10.1081/ddc-100102178, PMID 10071826.

Halakatti KP, Omer S, Gulgannavar SR, Kumar PP. Formulation and evaluation of mouth-disintegrating tablets of famotidine by using hibiscus ros sinensis mucilage and treated agar. Int J Res Ayurveda Pharm. 2010;1(2):497-505.

Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci. 2006;31(7):603-32. doi: 10.1016/j.progpolymsci.2006.06.001.

Antony PJ, Sanghavi NM. A new disintegrant for pharmaceutical dosage forms. Drug Dev Ind Pharm. 1997;23(4):413-5. doi: 10.3109/03639049709146146.

Kulkarni U, Rao NGR. Design and development of aceclofenac fast dissolving tablets by amorphous solid dispersion technique using modified Marmelos gum. Int J Pharm Res Dev. 2011;3(6):201-10.

Liew CV, Chan LW, Ching AL, Heng PWS. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm. 2006;309(1-2):25-37. doi: 10.1016/j.ijpharm.2005.10.040, PMID 16364576.

Pandey R, Ahmad Z, Sharma S, Khuller GK. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery. Int J Pharm. 2005;301(1-2):268-76. doi: 10.1016/j.ijpharm.2005.05.027. PMID 16023808.

Nayak RK, Patil SR, Patil BM, Mahalaxmi B. Evaluation of disintegrating properties of Mangifera indica gum. RGUHS J PharmSci. 2011;1(1):11-21.

Singh BS. Psyllium as therapeutic and drug delivery agent. Int J Pharm. 2007;334(1-2):1-14. doi: 10.1016/j.ijpharm.2007.01.028, PMID 17329047.

Ghenge GG, Pande SD, Ahmad A, Jejurkar L, Birari T. Development and characterization of the fast-disintegrating tablet of amlodipine besylate using mucilage of Plantago ovata as a natural super disintegrant. Int J PharmTech Res. 2011;3(2):938-45.

Dyer AM, Hinchcliffe M, Watts P, Castile J, Jabbal-Gill I, Nankervis R. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res. 2002;19(7):998-1008. doi: 10.1023/a:1016418523014. PMID 12180553.

Bagre AP, Jain K, Jain NK. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Int J Pharm. 2013;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. PMID 23994363.

Zhou N, Zan X, Wang Z, Wu H, Yin D, Liao C. Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydr Polym. 2013;94(1):420-9. doi: 10.1016/j.carbpol.2013.01.014. PMID 23544558.

Liu Z, Lv D, Liu S, Gong J, Wang D, Xiong M. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice. PLOS ONE. 2013;8(4):e60190. doi: 10.1371/journal.pone.0060190. PMID 23577091.

Cheng Y, Yu S, Wang J, Qian H, Wu W, Jiang X. In vitro and in vivo antitumor activity of doxorubicin-loaded alginic-acid-based nanoparticles. Macromol Biosci. 2012;12(10):1326-35. doi: 10.1002/mabi.201200165, PMID 22887841.

Ghosh D, Pramanik A, Sikdar N, Pramanik P. Synthesis of low molecular weight alginic acid nanoparticles through persulfate treatment as effective drug delivery system to manage drug resistant bacteria. Biotechnol Bioproc E. 2011;16(2):383-92. doi: 10.1007/s12257-010-0099-7.

Varshosaz J, Zaki MR, Minaiyan M, Banoozadeh J. Preparation, optimization, and screening of the effect of processing variables on agar nanospheres loaded with bupropion HCl by a D-optimal design. BioMed Res Int. 2015;2015:571816. doi: 10.1155/2015/571816, PMID 26090423.

El-Habashy SE, Allam AN, El-Kamel AH. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation. Int J Nanomedicine. 2016;11:2369-80. doi: 10.2147/IJN.S93354. PMID 27307735.

Vedula VB, Chopra M, Joseph E, Mazumder S. Preparation and characterization of nanoparticles of carboxymethyl cellulose acetate butyrate containing acyclovir. Appl Nanosci. 2016;6(2):197-208. doi: 10.1007/s13204-015-0421-y.

Nagarajan U, Kawakami K, Zhang S, Chandrasekaran B, Unni Nair B. Fabrication of solid collagen nanoparticles using electrospray deposition. Chem Pharm Bull (Tokyo). 2014;62(5):422-8. doi: 10.1248/cpb.c13-01004. PMID 24789924.

Moran MC, Rosell N, Ruano G, Busquets MA, Vinardell MP. Gelatin-based nanoparticles as DNA delivery systems: synthesis, physicochemical and biocompatible characterization. Colloids Surf B Biointerfaces. 2015;134:156-68. doi: 10.1016/j.colsurfb.2015.07.009. PMID 26188853.

Burapapadh K, Takeuchi H, Sriamornsak P. Novel pectin-based nanoparticles prepared from nanoemulsion templates for improving in vitro dissolution and in vivo absorption of poorly water-soluble drug. Eur J Pharm Biopharm. 2012;82(2):250-61. doi: 10.1016/j.ejpb.2012.07.010. PMID 22885158.

Izadi Z, Divsalar A, Saboury AA, Sawyer L. β-lactoglobulin-pectin nanoparticle-based oral drug delivery system for potential treatment of colon cancer. Chem Biol Drug Des. 2016;88(2):209-16. doi: 10.1111/cbdd.12748. PMID 26896377.

Chittasupho C, Jaturanpinyo M, Mangmool S. Pectin nanoparticle enhances cytotoxicity of methotrexate against HepG2 cells. Drug Deliv. 2013;20(1):1-9. doi: 10.3109/10717544.2012.739214, PMID 23216416.

Elzoghby AO. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. J Control Release. 2013;172(3):1075-91. doi: 10.1016/j.jconrel.2013.09.019, PMID 24096021.

Ezpeleta I, Irache JM, Stainmesse S, Chabenat C, Gueguen J, Popineau Y. Gliadin nanoparticles for the controlled release of all-trans-retinoic acid. International Journal of Pharmaceutics. 1996;131(2):191-200. doi: 10.1016/0378-5173(95)04338-1.

Xiao L, Lu G, Lu Q, Kaplan DL. Direct formation of silk nanoparticles for drug delivery. ACS Biomater Sci Eng. 2016;2(11):2050-7. doi: 10.1021/acsbiomaterials.6b00457, PMID 33440541.

Shen S, Li H, Yang W. The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier. Drug Deliv. 2014;21(7):501-8. doi: 10.3109/10717544.2014.895068, PMID 24625263.

Reddy BV, Navaneetha K. Formulation and evaluation of orodispersible tablets of candesartan. J Pharm Innov J. 2015;4(1):25-32. doi: 10.5530/pij.2015.1.6.

Kumar VS, Karthik N. Lovastatin fast dissolving tablets: formulation and in vitro evaluation. Appl Sci Rep. 2015;11(2):76-82. doi: 10.1007/s13596-014-0200-0.

Girish TK, Shalini M. Formulation and evaluation of taste masked orodispersible tablet of levocetirizine dihydrochloride. Boll Pharm Res. 2015;5(1):31-4. doi: 10.18231/2250-304X.2015.0007.

Pankaj S, Ashish D, Dheerendra R, Yogendra R, Ramakant J, Kuldeep S. Formulate and evaluate orodispersible tablets of primaquine. Indo Am J Pharm Res. 2015;5(5):1625-32. doi: 10.5281/zenodo.170557.

Swain R, Nagamani R, Panda S. Formulation, in vitro characterization and stability studies of fast dispersing tablets of diclofenac sodium. J App Pharm Sci. 2015;5(7):94-102. doi: 10.7324/JAPS.2015.50715.

Reshma J, Gangotri Y, Vaishali J, Ashish J. Formulation and evaluation of triphalaorodispersible tablet. Int J Pharm Life Sci. 2015;6(5):4491-4.

Srinivasan R, Vinod KK, Lakshmana G, Rajesh KD, Savinay KK. Mouth-dissolving tablets of meclizine hydrochloride by using super disintegrants formulation and in vitro evaluation. Int J Chem PharmSci. 2015;3(2):1533-6.

Kalyankar P, Panzade P, Lahoti S. Formulation design and optimization of orodispersible tablets of quetiapine fumarate by sublimation method. Indian J Pharm Sci. 2015;77(3):267-73. doi: 10.4103/0250-474x.159605, PMID 26180271.

Pinkal P, Jitendra P. Formulation development and evaluation of fast dissolving tablets of cyproheptadine hydrochloride. Pharm Sci Monit. 2014;5Suppl 1:247-55.

Dhadwe AK, Rathod CP, Vadvalkar SM, Ghiware NB, Gond NY, Shendarkar GR. Formulation and evaluation of orodispersible tablet of cinnarizine by direct compression method. World J Pharm Pharm Sci. 2014;3(5):588-601.

Ayyappan T, Poojitha C, Vetrichelvan T. Formulation design, optimization and in vitro evaluation of novel orodissolving tablets of efavirenz for HIV infections. Bangladesh J Sci Ind Res. 2014;49(3):173-80. doi: 10.3329/bjsir.v49i3.22131.